Dave Muggler, President & Founder
Dave is a healthcare industry veteran, having spent the past 20 years in life science market research and analytics. He has had Director roles with PDI, Syneos Health, and TGaS Advisors, a divison of Trinity. His work has spanned dozens of therapy areas, including many rare diseases. Dave has worked with clients that have managed products ranging from early-stage development to brand maturity.
With a passion for helping to improve health outcomes, the idea for PatientSight applies a proven subscription survey model to patients and caregivers. "With so much attention on physicians as the center of the commercial universe in pharma, I wanted to develop a tool that tracks patient perspectives about their healthcare journeys."
Dave and his family live in Yardley, PA. He is an avid sports, health, and fitness enthusiast.
Jason Fox, Chief Operating Officer & Co-Founder
Jason brings over 20 years experience in escalating roles of responsibility in the health care and pharmaceutical spaces. These roles have included management and oversight of teams and processes related to data analytics, client service, and operations. He has held Director and VP roles at Verispan, inVentiv, and Syneos Health, running their syndicated market research business lines.
Jason’s work has not only been focused on providing clients with quality data- it has also been about partnership and understanding client needs. He is excited about the opportunity that PatientSight has to become a trusted partner and source for companies developing and marketing products that benefit rare disease patients, who often lack effective treatments.
Jason holds a BA from Dickinson College and an MPA from the University of Delaware. He lives with his family in Bucks County, PA and enjoys golf and various sports outside the office.
Wes Michael, PatientSight Partner and Rare Patient Voice President & Founder
Wes Michael founded Rare Patient Voice in 2013 to give patients and family caregivers the opportunity to voice their opinions in research studies. This year the company celebrates its tenth anniversary. Rare Patient Voice has now conducted thousands of studies and rewarded patients and family caregivers with over $10 million for their participation. Many have been recruited in person by Wes and his team at patient events and through a robust referral program with patient advocacy and support groups. Rare Patient Voice now covers non-rare as well as rare diseases and conditions and has expanded from the United States to Canada, the United Kingdom, France, Germany, Italy, Spain, Australia, and New Zealand.
Before launching Rare Patient Voice, Wes worked for healthcare market research firm Kantar Health. He previously was a brand manager and market research manager at McCormick (the spice company) and General Mills (working on Wheaties, Total and Kix cereals). He has a BA from the University of Pennsylvania (with a year at Edinburgh University) and an MBA from the University of Chicago.
Wes lives outside Baltimore, Maryland, with his wife, Cathy, children Julia and Cliff, grandson Taylor, and dogs Ace and Stanley.
Pam Cusick, PatientSight Partner and Rare Patient Voice Senior Vice President
Pam Cusick is an experienced research professional with more than 30 years of expertise in study design, implementation, and analysis. Her background in public health communications and research, coupled with her passion for patient advocacy, dovetail with Rare Patient Voice’s mission and vision. She hopes to expand Rare Patient Voice’s panels to include all patients and caregivers who want to share their opinions and impact their disease category. Pam earned a BA in Psychology from Sweet Briar College, and a MA in Psychology from the New School for Social Research. She is Past-President of the Board of Directors and Scientific Advisory Council Lead for the Horses and Humans Research Foundation. As Senior Vice President, Pam’s focus is on the continued growth and success of RPV, with an eye on client services, business development, and oversight of patient outreach, panel management, and marketing.